Why the $11 billion Australian medtech sector’s supply chain is at risk of another “COVID” shock
The medtech sector needs further investment in manufacturing to protect against further potential global shocks as medical supply chains in Australia have not recovered fully from the COVID-19 pandemic which caused havoc with patient care. By Dr Jack Richards. In the face of threats like pandemics and shifting economic and geopolitical conditions, it’s imperative that…
Details